207 related articles for article (PubMed ID: 10770636)
1. Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors.
Yazawa K; Fujimori M; Amano J; Kano Y; Taniguchi S
Cancer Gene Ther; 2000 Feb; 7(2):269-74. PubMed ID: 10770636
[TBL] [Abstract][Full Text] [Related]
2. The genus Bifidobacterium for cancer gene therapy.
Fujimori M; Amano J; Taniguchi S
Curr Opin Drug Discov Devel; 2002 Mar; 5(2):200-3. PubMed ID: 11926126
[TBL] [Abstract][Full Text] [Related]
3. Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment.
Lemmon MJ; van Zijl P; Fox ME; Mauchline ML; Giaccia AJ; Minton NP; Brown JM
Gene Ther; 1997 Aug; 4(8):791-6. PubMed ID: 9338007
[TBL] [Abstract][Full Text] [Related]
4. Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth.
Li X; Fu GF; Fan YR; Liu WH; Liu XJ; Wang JJ; Xu GX
Cancer Gene Ther; 2003 Feb; 10(2):105-11. PubMed ID: 12536198
[TBL] [Abstract][Full Text] [Related]
5. Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer.
Fu GF; Li X; Hou YY; Fan YR; Liu WH; Xu GX
Cancer Gene Ther; 2005 Feb; 12(2):133-40. PubMed ID: 15565182
[TBL] [Abstract][Full Text] [Related]
6. [Antitumor efficacy of CD/5-FC suicide gene therapy system mediated by Bifidobacterium infantis against melanoma].
Yi C; Guo ZY; Huang Y; Wang HY; Wang SR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):165-8. PubMed ID: 15807256
[TBL] [Abstract][Full Text] [Related]
7. A new expression plasmid in Bifidobacterium longum as a delivery system of endostatin for cancer gene therapy.
Xu YF; Zhu LP; Hu B; Fu GF; Zhang HY; Wang JJ; Xu GX
Cancer Gene Ther; 2007 Feb; 14(2):151-7. PubMed ID: 17068487
[TBL] [Abstract][Full Text] [Related]
8. [Anaerobic bacteria as a gene delivery system for breast cancer therapy].
Fujimori M
Nihon Rinsho; 2008 Jun; 66(6):1211-8. PubMed ID: 18540373
[TBL] [Abstract][Full Text] [Related]
9. [Construction of Escherichia coli-Bifidobacterium longum shuttle vector and expression of tumor suppressor gene PTEN in B. longum].
Hou X; Liu JE
Wei Sheng Wu Xue Bao; 2006 Jun; 46(3):347-52. PubMed ID: 16933599
[TBL] [Abstract][Full Text] [Related]
10. Systemic NK4 gene therapy inhibits tumor growth and metastasis of melanoma and lung carcinoma in syngeneic mouse tumor models.
Kishi Y; Kuba K; Nakamura T; Wen J; Suzuki Y; Mizuno S; Nukiwa T; Matsumoto K; Nakamura T
Cancer Sci; 2009 Jul; 100(7):1351-8. PubMed ID: 19438869
[TBL] [Abstract][Full Text] [Related]
11. Bifidobacterium longum as a delivery system for gene therapy of chemically induced rat mammary tumors.
Yazawa K; Fujimori M; Nakamura T; Sasaki T; Amano J; Kano Y; Taniguchi S
Breast Cancer Res Treat; 2001 Mar; 66(2):165-70. PubMed ID: 11437103
[TBL] [Abstract][Full Text] [Related]
12. Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis.
Liu SC; Minton NP; Giaccia AJ; Brown JM
Gene Ther; 2002 Feb; 9(4):291-6. PubMed ID: 11896468
[TBL] [Abstract][Full Text] [Related]
13. Bifidobacterium longum as a delivery system of TRAIL and endostatin cooperates with chemotherapeutic drugs to inhibit hypoxic tumor growth.
Hu B; Kou L; Li C; Zhu LP; Fan YR; Wu ZW; Wang JJ; Xu GX
Cancer Gene Ther; 2009 Aug; 16(8):655-63. PubMed ID: 19229287
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effect of cytosine deaminase/5-fluorocytosine suicide gene therapy system mediated by Bifidobacterium infantis on melanoma.
Yi C; Huang Y; Guo ZY; Wang SR
Acta Pharmacol Sin; 2005 May; 26(5):629-34. PubMed ID: 15842785
[TBL] [Abstract][Full Text] [Related]
15. Tumor-Targeting Therapy Using Gene-Engineered Anaerobic-Nonpathogenic Bifidobacterium longum.
Taniguchi S; Shimatani Y; Fujimori M
Methods Mol Biol; 2016; 1409():49-60. PubMed ID: 26846801
[TBL] [Abstract][Full Text] [Related]
16. Systemic administration of attenuated Salmonella choleraesuis carrying thrombospondin-1 gene leads to tumor-specific transgene expression, delayed tumor growth and prolonged survival in the murine melanoma model.
Lee CH; Wu CL; Shiau AL
Cancer Gene Ther; 2005 Feb; 12(2):175-84. PubMed ID: 15375381
[TBL] [Abstract][Full Text] [Related]
17. Genetically engineered Bifidobacterium longum for tumor-targeting enzyme-prodrug therapy of autochthonous mammary tumors in rats.
Sasaki T; Fujimori M; Hamaji Y; Hama Y; Ito K; Amano J; Taniguchi S
Cancer Sci; 2006 Jul; 97(7):649-57. PubMed ID: 16827806
[TBL] [Abstract][Full Text] [Related]
18. Combined dendritic cell cryotherapy of tumor induces systemic antimetastatic immunity.
Machlenkin A; Goldberger O; Tirosh B; Paz A; Volovitz I; Bar-Haim E; Lee SH; Vadai E; Tzehoval E; Eisenbach L
Clin Cancer Res; 2005 Jul; 11(13):4955-61. PubMed ID: 16000595
[TBL] [Abstract][Full Text] [Related]
19. Effective transfer of interleukin-12 gene to solid tumors using a novel gene delivery system, poly [D,L-2,4-diaminobutyric acid].
Iwashita Y; Ogawa T; Goto S; Nakanishi M; Goto T; Kitano S
Cancer Gene Ther; 2004 Feb; 11(2):103-8. PubMed ID: 14671674
[TBL] [Abstract][Full Text] [Related]
20. Intravenous injection of siRNA directed against hypoxia-inducible factors prolongs survival in a Lewis lung carcinoma cancer model.
Kamlah F; Eul BG; Li S; Lang N; Marsh LM; Seeger W; Grimminger F; Rose F; Hänze J
Cancer Gene Ther; 2009 Mar; 16(3):195-205. PubMed ID: 18818708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]